Yahoo Web Search

  1. Ads
    related to: Dupixent
    • Analyst Report: Regeneron Pharmaceuticals, Inc.

      Morningstar Research via Yahoo Finance· 1 day ago

      The company has several marketed products including: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL...

    • Regeneron Earnings Lift Stock. Here's Why.

      Barron s Online· 2 days ago

      Regeneron (ticker: REGN) reported first-quarter revenues of $2.5 billion, up 38% from the first quarter of 2020. The revenue figure matched the FactSet consensus estimate of $2.5 billion, but ...

  1. Ads
    related to: Dupixent